FIBROCELL SCIENCE INC's ticker is FCSC and the CUSIP is 315721209. A total of 32 filers reported holding FIBROCELL SCIENCE INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,310,000 | -12.5% | 2,078,877 | 0.0% | 0.07% | -45.5% |
| Q3 2016 | $1,497,000 | -37.4% | 2,078,877 | 0.0% | 0.12% | -22.4% |
| Q2 2016 | $2,391,000 | -54.0% | 2,078,877 | 0.0% | 0.16% | -42.6% |
| Q1 2016 | $5,197,000 | -43.5% | 2,078,877 | +2.9% | 0.27% | -30.3% |
| Q4 2015 | $9,194,000 | +19.5% | 2,020,666 | +1.2% | 0.39% | +54.2% |
| Q3 2015 | $7,691,000 | -15.5% | 1,997,644 | +15.6% | 0.25% | +37.5% |
| Q2 2015 | $9,105,000 | +16.9% | 1,727,644 | 0.0% | 0.18% | 0.0% |
| Q1 2015 | $7,792,000 | +74.1% | 1,727,644 | 0.0% | 0.18% | +73.6% |
| Q4 2014 | $4,475,000 | -10.7% | 1,727,644 | 0.0% | 0.11% | -29.8% |
| Q3 2014 | $5,010,000 | -27.3% | 1,727,644 | 0.0% | 0.15% | -16.1% |
| Q2 2014 | $6,893,000 | -23.7% | 1,727,644 | 0.0% | 0.18% | -47.5% |
| Q1 2014 | $9,036,000 | +24.6% | 1,727,644 | -3.3% | 0.34% | +15.9% |
| Q4 2013 | $7,251,000 | -7.3% | 1,786,000 | 0.0% | 0.30% | +0.7% |
| Q3 2013 | $7,823,000 | -0.6% | 1,786,000 | +38.9% | 0.29% | -31.8% |
| Q2 2013 | $7,870,000 | – | 1,286,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 16,620,414 | $63,989,000 | 2.55% |
| Healthcare Value Capital, LLC | 147,769 | $569,000 | 0.81% |
| Trellus Management Company, LLC | 114,936 | $443,000 | 0.65% |
| AKANTHOS CAPITAL MANAGEMENT LLC | 50,000 | $192,000 | 0.29% |
| MSD Partners, L.P. | 1,997,644 | $7,691,000 | 0.25% |
| QVT Financial LP | 1,870,556 | $7,202,000 | 0.25% |
| Context Capital Management, LLC | 31,010 | $119,000 | 0.22% |
| Geduld E E | 20,100 | $77,000 | 0.07% |
| EMERALD ADVISERS, LLC | 324,425 | $1,249,000 | 0.06% |
| STALEY CAPITAL ADVISERS INC | 110,000 | $423,000 | 0.05% |